These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27404213)

  • 1. Epidemiology of Vasopressin Use for Adults with Septic Shock.
    Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Vasopressin Rebranding and Utilization in Patients With Septic Shock.
    Sacha GL; Kiser TH; Wright GC; Vandivier RW; Moss M; Burnham EL; Ho PM; Reynolds PM; Bauer SR
    Crit Care Med; 2022 Apr; 50(4):644-654. PubMed ID: 34605778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
    Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
    Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications of vasopressin in the management of septic shock].
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):600-8. PubMed ID: 12946492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin as an inotrope in refractory septic shock.
    Habaragamuwa BW; Lamahewage N; Piyasiri CA
    Ceylon Med J; 2010 Mar; 55(1):31-2. PubMed ID: 20449918
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J; Cai H; Zheng X
    BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is vasopressin an ideal vasopressor to treat hypotension in septic shock?
    Romand JA; Treggiari-Venzi M
    Intensive Care Med; 1999 Jul; 25(7):763-4. PubMed ID: 10577013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.